2 Life Science Cos. Pull IPOs Over Weak Market Conditions
Private-equity backed Swiss biotech Basilea Pharmaceutica Ltd. yanked its $190 million initial public offering, one of two life science companies to pull IPOs Wednesday due to weak market conditions, marking a...To view the full article, register now.
Already a subscriber? Click here to view full article